Sensor-augmented pump therapy with automated insulin suspension reduced the combined rate of severe (hypoglycemic seizure or coma) and moderate (hypoglycemia requiring assistance from another person) hypoglycemia in T1DM patients. Here, INS is linked to type 2 diabetes mellitus.